FDA Approves Pirtobrutinib for Previously Untreated Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
The FDA approved pirtobrutinib for untreated chronic lymphocytic leukemia and small lymphocytic lymphoma without 17p deletion.
ALL ABOUT DAILYZ HEALTH NEWS
ALL ABOUT DAILYZ HEALTH NEWS
August 08, 2023 2 min read Source/Disclosures Published by: Disclosures: Aguilar and Swetschinski report no relevant financial disclosures. Please see
Read MoreA sign asking Ohioans to vote in support of Issue 1 sits above another sign advocating against abortion rights at
Read MoreToxoplasma brain parasites can cause personality alterations. Of all causes of foodborne disease, a brain parasite called toxoplasma is ranked
Read MoreCredit: Getty Images. Burnout — a term physicians are all too familiar with. Grueling hours, demanding work, administrative burdens, and
Read MoreAugust 08, 2023 2 min read Source/Disclosures Disclosures: Olfson reports being a research psychiatrist for the New York State Office
Read MoreAniya was ready to leave. She was dressed in a fuzzy white onesie her mother had packed for her first
Read MorePharmaceutical giant Novo Nordisk has turned to influential Black Americans in pursuit of what would be a lucrative victory: having
Read MoreWith tens of millions of Americans burdened by medical debt, hospitals and other medical providers are increasingly shuttling their patients
Read MoreSource/Disclosures Disclosures: Fitzgerald reports receiving grants from the NIH. Chiotos reports no relevant financial disclosures. Please see the study for
Read MoreWhen Dr. Tra’chella Johnson Foy greets her patients, she sits across from them facing away from the computer in the
Read More